Mesoblast
MESO
23 hedge funds and large institutions have $23M invested in Mesoblast in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.
61% more capital invested
Capital invested by funds: $14.3M → $23M (+$8.74M)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
5% more funds holding
Funds holding: 22 → 23 (+1)
0.02% more ownership
Funds ownership: 0.27% → 0.29% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$2.87M |
| 2 |
Renaissance Technologies
New York
|
+$748K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$466K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$231K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$167K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$2.49M |
| 2 |
PP
Prudential plc
London, England,
United Kingdom
|
-$227K |
| 3 |
PM
Penbrook Management
New York
|
-$69.2K |
| 4 |
PCM
Princeton Capital Management
Red Bank,
New Jersey
|
-$8.69K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$6.42K |
MESO Hedge Fund Activity: Q3 2018 in Review
23 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q3 2018, worth a combined $23M — up 61% from $14.3M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MESO positions and 2 closed out — a net gain of 1 holder — while 7 added to existing stakes and 5 trimmed.
The largest buyer was Capital World Investors, opening a new position worth an estimated $2.87M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $2.49M sold.
- 23 institutional investors held Mesoblast (MESO) as of Q3 2018, up from 22 in Q2 2018.
- Funds reported $23M of Mesoblast stock for Q3 2018, up 61% quarter-over-quarter.
- 3 funds opened new Mesoblast positions in Q3 2018 and 2 closed out, a net change of +1 holder.
- The largest Mesoblast buyer in Q3 2018 was Capital World Investors, an estimated $2.87M added.
- The largest Mesoblast seller in Q3 2018 was Capital Research Global Investors, an estimated $2.49M sold.
Based on aggregated 13F filings for Q3 2018.